Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chorionic gonadotropin in weight control. A double-blind crossover study

R L Young, R J Fuchs, M J Woltjen

    JAMA
    |November 29, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The nutrient-sensing repertoires of mouse enterochromaffin cells differ between duodenum and colon.

    Neurogastroenterology and motility·2017
    Same author

    Lipid stimulation of fatty acid sensors in the human duodenum: relationship with gastrointestinal hormones, BMI and diet.

    International journal of obesity (2005)·2016
    Same author

    From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.

    Molecular psychiatry·2016
    Same author

    Life history as a constraint on plasticity: developmental timing is correlated with phenotypic variation in birds.

    Heredity·2015
    Same author

    The 4-H youth organization: Primary prevention through competency promotion.

    The journal of primary prevention·2013
    Same author

    Modulation of murine gastric vagal afferent mechanosensitivity by neuropeptide W.

    Acta physiologica (Oxford, England)·2013
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Human chorionic gonadotropin (HCG) did not show significant weight reduction benefits compared to placebo in a double-blind study. This study found no statistical difference in weight loss or patient outcomes between the two groups.

    Area of Science:

    • Endocrinology
    • Metabolism
    • Clinical Trials

    Background:

    • Obesity is a significant global health concern requiring effective management strategies.
    • Human chorionic gonadotropin (HCG) has been anecdotally suggested for weight reduction.
    • Evidence-based evaluation of HCG for weight loss is necessary.

    Purpose of the Study:

    • To evaluate the efficacy of human chorionic gonadotropin (HCG) versus placebo for weight reduction.
    • To assess the impact of HCG on weight, body composition, and patient-reported outcomes.

    Main Methods:

    • A double-blind, randomized, cross-over study design was employed.
    • Two hundred two patients were enrolled in the study.
    • Measurements included weight, skin-fold thickness, dropout rates, and subjective patient response.

    Related Experiment Videos

    Main Results:

    • No statistically significant difference in weight reduction was observed between the HCG and placebo groups (P > 0.1).
    • Skin-fold thickness measurements showed no significant variation between treatment arms.
    • Dropout rates and patient subjective responses did not differ significantly between groups.

    Conclusions:

    • Human chorionic gonadotropin (HCG) is not more effective than placebo for weight reduction.
    • Current evidence does not support the use of HCG in weight management programs.
    • Further research may be warranted to explore other potential therapeutic applications of HCG.